Peripheral Artery Disease
348
50
62
189
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
64 trials with published results (18%)
Research Maturity
189 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.2%
18 terminated out of 348 trials
91.3%
+4.8% vs benchmark
9%
33 trials in Phase 3/4
34%
64 of 189 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 189 completed trials
Clinical Trials (348)
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
Red Light Treatment in Peripheral Artery Disease
REGistry of Long-term AnTithrombotic TherApy-1
Stents Post-dilation With DCB or POBA in Femoropopliteal Arteries
Exercise Therapy for PAD Using Mobile Health
The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
Improve PAD PERformance With METformin
BEETroot Juice to Reverse Functional Impairment in PAD
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
ENhancing Exercise With LIGHT to Improve Functioning in PAD
Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease
Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation
Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease
Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function in PAD
Durg Coated Balloon Angioplasty in Infrapopliteal Lesions
The THOR IDE Study
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
3-year Follow-up of Patients Treated With Jetstream Combined With Ranger for Calcified Femoropopliteal Lesions